{"id":5540,"date":"2018-06-30T13:50:00","date_gmt":"2018-06-30T13:50:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5540"},"modified":"2024-05-02T11:18:20","modified_gmt":"2024-05-02T09:18:20","slug":"shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/","title":{"rendered":"Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yamasaki+S&amp;cauthor_id=30540999\">Satoko Yamasaki<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Sakata+Y&amp;cauthor_id=30540999\">Yasuhisa Sakata<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-2\">2<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yoshida+H&amp;cauthor_id=30540999\">Hisako Yoshida<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Shirai+S&amp;cauthor_id=30540999\">Sinpei Shirai<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tanaka+Y&amp;cauthor_id=30540999\">Yuichiro Tanaka<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Nakano+R&amp;cauthor_id=30540999\">Ryo Nakano<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yukimoto+T&amp;cauthor_id=30540999\">Takahiro Yukimoto<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tsuruoka+N&amp;cauthor_id=30540999\">Nanae Tsuruoka<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Shimoda+R&amp;cauthor_id=30540999\">Ryo Shimoda<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fukuda+M&amp;cauthor_id=30540999\">Makoto Fukuda<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Miyazono+M&amp;cauthor_id=30540999\">Motoaki Miyazono<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ikeda+Y&amp;cauthor_id=30540999\">Yuji Ikeda<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Iwakiri+R&amp;cauthor_id=30540999\">Ryuichi Iwakiri<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Anzai+K&amp;cauthor_id=30540999\">Keizo Anzai<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fujimoto+K&amp;cauthor_id=30540999\">Kazuma Fujimoto<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/#affiliation-1\">1<\/a><\/sup> , Digestion. 2019;100(4):247-253.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Background:\u00a0<\/strong>Leukocyte removal therapy (LRT) is an effective treatment for active ulcerative colitis (UC). The present study was performed to evaluate the relapse-free period after LRT and identify risk factors for relapse. <strong>Methods:\u00a0<\/strong>In total, 94 patients who underwent first-time LRT for remission of moderate to severe UC from April 2004 to March 2016 were enrolled in the present study. The patients were randomly assigned to one of 2 treatments: leukocytapheresis (LCAP; n = 43) or granulocyte and monocyte\/macrophage adsorptive apheresis (GMA; n = 51). The 5-year cumulative relapse-free rate and risk factors for relapse were evaluated. <strong>Results:\u00a0<\/strong>The therapeutic response rate was 82% for GMA and 70% for LCAP without a statistically significant difference. The 5-year relapse-free rate was 34.7% in the LRT group. The 5-year relapse-free rate in patients aged > 40 years was 49.9%, which was significantly higher than that in patients aged \u226440 years (22.9%, p &lt; 0.01). The relapse-free period was longer in the older than younger patients. The relapse-free period was longer in the \u226540- than &lt;40-year-old patients (1,197 vs. 441 days, respectively; p = 0.03). <strong>Conclusions:\u00a0<\/strong>The relapse-free period after LRT was examined in patients with UC, and 34.7% of patients achieved clinical remission within a 5-year period. The risk factor for early relapse after LRT was younger age.  In conclusion, LRT might be a therapeutic option for maintenance of remission in patients with UC, especially patients aged \u226540 years.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30540999\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Satoko Yamasaki&nbsp;1,&nbsp;Yasuhisa Sakata&nbsp;2,&nbsp;Hisako Yoshida&nbsp;3,&nbsp;Sinpei Shirai&nbsp;1,&nbsp;Yuichiro Tanaka&nbsp;1,&nbsp;Ryo Nakano&nbsp;1,&nbsp;Takahiro Yukimoto&nbsp;1,&nbsp;Nanae Tsuruoka&nbsp;1,&nbsp;Ryo Shimoda&nbsp;1,&nbsp;Makoto Fukuda&nbsp;1,&nbsp;Motoaki Miyazono&nbsp;1,&nbsp;Yuji Ikeda&nbsp;1,&nbsp;Ryuichi Iwakiri&nbsp;1,&nbsp;Keizo Anzai&nbsp;1,&nbsp;Kazuma Fujimoto&nbsp;1 , Digestion. 2019;100(4):247-253. Background:\u00a0Leukocyte removal therapy (LRT) is an effective treatment for active ulcerative colitis (UC). The present study was performed to evaluate the relapse-free period after LRT and identify risk factors for relapse. Methods:\u00a0In total, 94 patients who [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[147,310,451,74,81,306],"class_list":["post-5540","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-clinical-remission","scientific_tags-elderly","scientific_tags-induction","scientific_tags-leukocytapheresis","scientific_tags-long-term-outcome","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Satoko Yamasaki&nbsp;1,&nbsp;Yasuhisa Sakata&nbsp;2,&nbsp;Hisako Yoshida&nbsp;3,&nbsp;Sinpei Shirai&nbsp;1,&nbsp;Yuichiro Tanaka&nbsp;1,&nbsp;Ryo Nakano&nbsp;1,&nbsp;Takahiro Yukimoto&nbsp;1,&nbsp;Nanae Tsuruoka&nbsp;1,&nbsp;Ryo Shimoda&nbsp;1,&nbsp;Makoto Fukuda&nbsp;1,&nbsp;Motoaki Miyazono&nbsp;1,&nbsp;Yuji Ikeda&nbsp;1,&nbsp;Ryuichi Iwakiri&nbsp;1,&nbsp;Keizo Anzai&nbsp;1,&nbsp;Kazuma Fujimoto&nbsp;1 , Digestion. 2019;100(4):247-253. Background:\u00a0Leukocyte removal therapy (LRT) is an effective treatment for active ulcerative colitis (UC). The present study was performed to evaluate the relapse-free period after LRT and identify risk factors for relapse. Methods:\u00a0In total, 94 patients who [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T09:18:20+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/\",\"name\":\"Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2018-06-30T13:50:00+00:00\",\"dateModified\":\"2024-05-02T09:18:20+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/","og_locale":"es_ES","og_type":"article","og_title":"Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis - Adacyte","og_description":"Satoko Yamasaki&nbsp;1,&nbsp;Yasuhisa Sakata&nbsp;2,&nbsp;Hisako Yoshida&nbsp;3,&nbsp;Sinpei Shirai&nbsp;1,&nbsp;Yuichiro Tanaka&nbsp;1,&nbsp;Ryo Nakano&nbsp;1,&nbsp;Takahiro Yukimoto&nbsp;1,&nbsp;Nanae Tsuruoka&nbsp;1,&nbsp;Ryo Shimoda&nbsp;1,&nbsp;Makoto Fukuda&nbsp;1,&nbsp;Motoaki Miyazono&nbsp;1,&nbsp;Yuji Ikeda&nbsp;1,&nbsp;Ryuichi Iwakiri&nbsp;1,&nbsp;Keizo Anzai&nbsp;1,&nbsp;Kazuma Fujimoto&nbsp;1 , Digestion. 2019;100(4):247-253. Background:\u00a0Leukocyte removal therapy (LRT) is an effective treatment for active ulcerative colitis (UC). The present study was performed to evaluate the relapse-free period after LRT and identify risk factors for relapse. Methods:\u00a0In total, 94 patients who [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T09:18:20+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/","name":"Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2018-06-30T13:50:00+00:00","dateModified":"2024-05-02T09:18:20+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/shorter-relapse-free-period-after-leukocyte-removal-therapy-in-younger-than-older-patients-with-ulcerative-colitis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5540"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}